NTRA
NateraCNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
+
Peers tracked
10
U.S. public peers
Grade Position
In line
vs peer average
NTRA vs peer average
47/100
NTRA vs. peer average (C vs. C)
Grade spread
A 1 · B 5 · C 1 · D 1 · F 2
Graded peers loaded
Coverage
10 graded
100% of tracked
Peer overview
GH is the first available peer comparator.
Guardant Health is a more direct oncology liquid-biopsy and cancer-monitoring comparator than the packet's broad sector peers. Public filings and competitive disclosures identify Natera, Guardant, Exact Sciences, Myriad, Tempus, Caris, NeoGenomics and others as competing across liquid biopsy, genomic profiling, MRD, or treatment-monitoring markets, making GH a relevant read-through for MRD adoption and reimbursement competition.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
NTRA
Natera
GH
Guardant Health
Grade
C
B
Momentum
45
95
Value
48
36
Sentiment
62
37
Setup Bias
Net Bullish
-
Market Cap
-
-
Posture
Mixed
Constructive
Grade position vs GH
NTRA / GH
Grade Position
In line
NTRA vs. peer average (C vs. C)
47/100
Momentum
45
GHValue
48
NTRASentiment
62
NTRARotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs NTRA
GH is the first peer returned for this comparison set.